Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.31492 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.94612 | 66 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.28242 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.21852 | 68 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.04813 | 67 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.38053 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.34242 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.23033 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.22652 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.1886 | 68 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.40888 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.23018 | 69 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.04531 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.23267 | 69 |